[HTML][HTML] Old and new systemic immune-inflammation indexes are associated with overall survival of glioblastoma patients treated with radio-chemotherapy

…, E Natali, P Chiarugi, A Gonnelli, M Cantarella… - Genes, 2022 - mdpi.com
Background. Systemic immunity and inflammation indexes (SI) derived from blood cells have
gained increasing attention in clinical oncology as potential biomarkers that are associated …

Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma

…, N Giannini, G Gadducci, G Malfatti, M Cantarella… - Acta Neurologica …, 2022 - Springer
The impact of different patterns of glioblastoma (GBM) recurrence has not yet been fully
established in patients suitable for a second surgery. Through the present observational study …

Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy

…, M Gabelloni, A Gonnelli, L Faggioni, M Cantarella… - La radiologia …, 2022 - Springer
Background There is an unmet need for new biomarkers able to predict both the outcomes
of up–front therapy and the compliance of elderly patients diagnosed with glioblastoma. For …

Role of magnetic resonance imaging following postoperative radiotherapy in clinical decision-making of patients with high-grade glioma

F Pasqualetti, G Malfatti, M Cantarella, A Gonnelli… - La radiologia …, 2022 - Springer
Objectives The present study aims to investigate the role of the first magnetic resonances (MRI)
following radio-chemotherapy (RT-CT) in patients diagnosed with high-grade glioma. …

Clinical outcomes of stereotactic body radiotherapy in oligometastatic gynecological cancer

…, R Morganti, C Greco, M Cantarella… - International Journal of …, 2017 - ijgc.bmj.com
Objective The objective of this study was to assess the role of stereotactic body radiotherapy
(SBRT) in the treatment of distantly recurrent, oligometastatic gynecological cancer. …

[HTML][HTML] [18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer

…, A Gonnelli, A Molinari, M Cantarella… - European Journal of …, 2020 - Springer
Background In the last years, functional imaging has given a significant contribution to the
clinical decision-making of biochemically relapsed prostate cancer (PCa). Hereby, we present …

Image-guided stereotactic body radiotherapy in metastatic prostate cancer

…, R Morganti, G Coraggio, M Cantarella… - Anticancer …, 2018 - ar.iiarjournals.org
Background/Aim: In the last years, the use of Image Guided Stereotactic Radiotherapy (IG-SBRT)
in patients with metastatic prostate cancer has increased. In this study, we aimed to …

Stereotactic body radiotherapy of bone metastases in oligometastatic disease: prognostic factors of oncologic outcomes

S Ursino, S Montrone, M Cantarella… - Tumori …, 2016 - journals.sagepub.com
Background To evaluate the safety of stereotactic body radiotherapy (SBRT) of bone
metastases in oligometastatic disease and to investigate prognostic factors of local control (LC), …

[HTML][HTML] IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients

…, A Gonnelli, M Ruglioni, GI Luculli, M Cantarella… - BMC cancer, 2024 - Springer
Background Circulating cell-free DNA (cfDNA, liquid biopsy) is a powerful tool to detect
molecular alterations. However, depending on tumor characteristics, biology and anatomic …

Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio …

F Pasqualetti, A Gonnelli, M Cantarella… - Investigational new …, 2018 - Springer
Glioblastoma (GBM) is the most frequent malignant primary brain tumor in adults and, despite
recent advances, the prognosis for this cancer remains dismal. The aims of this study were …